354 related articles for article (PubMed ID: 8868981)
1. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.
Omland T; Aakvaag A; Vik-Mo H
Heart; 1996 Sep; 76(3):232-7. PubMed ID: 8868981
[TBL] [Abstract][Full Text] [Related]
2. [Cardiac natriuretic peptides as markers of left ventricular dysfunction].
Omland T; Aakvaag A; Vik-Mo H
Tidsskr Nor Laegeforen; 1997 Mar; 117(7):943-8. PubMed ID: 9103004
[TBL] [Abstract][Full Text] [Related]
3. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
[TBL] [Abstract][Full Text] [Related]
4. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.
Hammerer-Lercher A; Neubauer E; Müller S; Pachinger O; Puschendorf B; Mair J
Clin Chim Acta; 2001 Aug; 310(2):193-7. PubMed ID: 11498085
[TBL] [Abstract][Full Text] [Related]
5. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
[TBL] [Abstract][Full Text] [Related]
6. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.
Talwar S; Squire IB; Downie PF; Mccullough AM; Campton MC; Davies JE; Barnett DB; Ng LL
Eur Heart J; 2000 Sep; 21(18):1514-21. PubMed ID: 10973765
[TBL] [Abstract][Full Text] [Related]
7. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.
Bonarjee VV; Omland T; Nilsen DW; Caidahl K; Sundsfjord JA; Dickstein K
Br Heart J; 1995 Jun; 73(6):511-6. PubMed ID: 7626348
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction.
Muders F; Kromer EP; Griese DP; Pfeifer M; Hense HW; Riegger GA; Elsner D
Am Heart J; 1997 Sep; 134(3):442-9. PubMed ID: 9327700
[TBL] [Abstract][Full Text] [Related]
9. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
Vasan RS; Benjamin EJ; Larson MG; Leip EP; Wang TJ; Wilson PW; Levy D
JAMA; 2002 Sep; 288(10):1252-9. PubMed ID: 12215132
[TBL] [Abstract][Full Text] [Related]
10. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
[TBL] [Abstract][Full Text] [Related]
12. Third heart sound revisited: a correlation with N-terminal pro brain natriuretic peptide and echocardiography to detect left ventricular dysfunction.
Narain VS; Puri A; Gilhotra HS; Sadiq PA; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2005; 57(1):31-4. PubMed ID: 15852891
[TBL] [Abstract][Full Text] [Related]
13. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
[TBL] [Abstract][Full Text] [Related]
14. Pericardial fluid and serum biomarkers equally predict ventricular dysfunction.
Amjad S; Sami SA; Basir MN; Hameed K; Fujita M; Ahmad HR
Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):160-5. PubMed ID: 24532613
[TBL] [Abstract][Full Text] [Related]
15. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population.
Nakamura M; Endo H; Nasu M; Arakawa N; Segawa T; Hiramori K
Heart; 2002 Feb; 87(2):131-5. PubMed ID: 11796549
[TBL] [Abstract][Full Text] [Related]
16. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population.
Talwar S; Squire IB; Davies JE; Barnett DB; Ng LL
Eur Heart J; 1999 Dec; 20(23):1736-44. PubMed ID: 10562482
[TBL] [Abstract][Full Text] [Related]
17. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
[TBL] [Abstract][Full Text] [Related]
18. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.
Haug C; Metzele A; Kochs M; Hombach V; Grünert A
Clin Cardiol; 1993 Jul; 16(7):553-7. PubMed ID: 8348764
[TBL] [Abstract][Full Text] [Related]
19. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
20. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
Selvais PL; Donckier JE; Robert A; Laloux O; van Linden F; Ahn S; Ketelslegers JM; Rousseau MF
Eur J Clin Invest; 1998 Aug; 28(8):636-42. PubMed ID: 9767358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
